ChemAxon
ChemAxon is a Hungary-based cheminformatics software company serving 600+ pharmaceutical, biotechnology, CRO, and academic customers across 130+ countries with tools for molecule design, chemical drawing, compound registration, and compliance management. Acquired by Certara for $90 million in October 2024.
- Company typePrivate
- Founded1998
- HeadquartersUtica, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What ChemAxon does
ChemAxon is a cheminformatics software company that builds tools for property calculation, molecule design, chemical drawing, chemical search, and compound data management. Its product suite comprises Marvin (chemical drawing), Design Hub (collaborative molecular design and tracking), Compound Registration (end-to-end chemical registration), Compliance Checker and cHemTS (instant chemical compliance across synthesis, shipping, and storage), JChem Engines (chemical search engine built for databases in the tens of millions), and Discovery Toolkits (cheminformatics SDKs). The platform primarily serves pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions across 130+ countries. ChemAxon operates under a software licensing, subscription-based revenue model sold via an enterprise field sales motion with consultation-based selling and academic discounts; 750,000+ users at 600+ industry-leading companies use ChemAxon tooling, including Bayer and Cancer Research Horizon.
Following the October 2024 acquisition by Certara, Inc. (NASDAQ: CERT) for $90 million in cash, ChemAxon operates as a wholly-owned subsidiary integrated with Certara's biosimulation, scientific informatics, and AI platforms (Simcyp, Phoenix, D360, Certara.AI). The strategic intent is to close gaps in the design-make-test-analyze cycle by funneling ChemAxon-derived chemistry into Certara's biosimulation and regulatory offerings. Founded in 1998 and headquartered in Budapest, Hungary, ChemAxon had 101-250 employees and was led by CEO Richard Jones following founders Ferenc Csizmadia and Péter Csizmadia; the global chemoinformatics market in which it operates is projected to grow from $4.51B in 2025 to $19.12B by 2035.
ChemAxon firmographics
Firmographics- Name
- ChemAxon
- Legal name
- Chemaxon Ltd.
- Website
- https://chemaxon.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- ChemAxon is a Hungary-based cheminformatics software company serving 600+ pharmaceutical, biotechnology, CRO, and academic customers across 130+ countries with tools for molecule design, chemical drawing, compound registration, and compliance management. Acquired by Certara for $90 million in October 2024.
- Ownership category
- akta.pro rank
ChemAxon industry classification
Industry- Product category
- Cheminformatics Software
- akta.pro primary industry
- Cheminformatics & Molecular Modeling / CADD (HLAGAJAE)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)
Keywords
Where ChemAxon is headquartered
LocationHeadquarters
- HQ city
- Utica
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ChemAxon business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing: Software licensing model providing cheminformatics solutions including Marvin, Design Hub, Compound Registration, Compliance Checker, JChem Engines, and Discovery Toolkits
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Academic Discount Program |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
ChemAxon product offering
Product offeringCore offering
ChemAxon develops and licenses cheminformatics software for drug discovery. Its product suite covers property calculation, molecule design, chemical drawing, chemical search, and compound data management across the design-make-test-analyze (DMTA) cycle. Core offerings include Marvin (chemical drawing), Design Hub (collaborative molecular design), Compound Registration, Compliance Checker / cHemTS, JChem Engines (chemical search), and Discovery Toolkits (SDKs for custom cheminformatics applications).
Product overview
Chemaxon is a suite of cheminformatics software solutions for drug discovery, comprising multiple integrated products that work together across the design-make-test-analyze cycle. The core portfolio includes Marvin for chemical drawing, Design Hub for molecular design collaboration, Compound Registration for end-to-end registration, Compliance Checker and cHemTS for regulatory compliance, JChem Engines for chemical database searching, and Discovery Toolkits for custom application development. These products collectively provide capabilities for property calculation, molecule design, chemical drawing, chemical search, and compound data management, enabling researchers to streamline drug discovery workflows from early design through regulatory submission.
Differentiator
Problem solved
Functional benefit
Brands
- Marvin: Chemical drawing tool for research scientists providing industry-standard chemical intelligence.
- Design Hub
- Compound Registration
- Compliance Checker and cHemTS
- JChem Engines
- Discovery Toolkits
Products and services
- Marvin Chemical drawing tool providing universal chemical drawing capabilities for research scientists with industry-standard chemical intelligence.
- Design Hub Molecular design and tracking platform that enables collaborative drug discovery by allowing teams to design and track molecular candidates.
- Compound Registration End-to-end chemical registration system providing automated compound registration capabilities for drug discovery workflows.
- Compliance Checker and cHemTS Chemical compliance verification tool providing instant validation across synthesis, shipping, and storage requirements.
- JChem Engines Chemical search engine optimized for querying large chemical databases containing tens of millions of molecular structures.
- Discovery Toolkits Collection of cheminformatics tools and software development kits for building custom drug discovery applications and workflows.
Quantifiable outcome
- Scale chemical search to hundreds of millions to billions of chemical structures
- +1 more outcomes
Companies that use ChemAxon
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
ChemAxon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
ChemAxon partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CertaracoreCertara, Inc. completed the acquisition of Chemaxon Ltd. in October 2024 for $90 million in cash. The acquisition aims to integrate Chemaxon's cheminformatics and bioinformatics software with Certara's biosimulation solutions to enhance drug discovery and development capabilities.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
ChemAxon competitors and assessment
Company assessmentRegional players
- Molecular Connections: India-based scientific informatics and data management services provider serving pharma R&D. Adjacent competitor in chemistry data curation and cheminformatics workflows, primarily serving global pharma from a regional base.
Broad incumbents
- BIOVIA (Dassault Systèmes): Enterprise scientific software portfolio covering molecular modeling, lab informatics, and chemistry. Competes broadly with ChemAxon in cheminformatics and compound registration but as part of a much larger PLM/3DEXPERIENCE suite.
- Elsevier (Reaxys): Chemistry and reaction database with embedded cheminformatics tools used by pharma R&D. Competes with ChemAxon's chemical search and property prediction, particularly in medicinal chemistry workflows.
- PerkinElmer Informatics (Revvity Signals): Enterprise scientific informatics suite including chemistry, biology, and lab workflows. Overlaps with ChemAxon on registration, search, and discovery informatics across pharma R&D.
Emerging players
- Collaborative Drug Discovery (CDD): Cloud-based drug discovery informatics platform with chemical registration, activity databases, and collaboration features. Overlaps with ChemAxon's Compound Registration and JChem Engines capabilities for smaller biotech and academic groups.
- Scilligence: Cheminformatics and biology informatics tools (e.g., ELN, registration, search) for pharma and biotech. Direct functional overlap with ChemAxon on compound registration and chemical search at smaller scale.
Direct peers
- Schrödinger: Computational chemistry and molecular simulation platform serving pharma and biotech drug discovery. Overlaps with ChemAxon on molecule design, property prediction, and cheminformatics-driven lead optimization workflows.
- Dotmatics: Scientific R&D informatics platform for chemistry, biology, and lab data management. Competes with ChemAxon on compound registration, chemical search, and collaborative molecule design for pharma/biotech.
- ACD/Labs: Chemistry software for property prediction, analytical data handling, and chemical informatics. Direct overlap with ChemAxon on chemical drawing, property calculation, and analytical/compliance workflows.
- OpenEye Scientific (Cadence Design Systems): Cheminformatics and molecular modeling software (formerly OpenEye) focused on small-molecule design, search, and conformer generation. Direct competitor to ChemAxon in pharma drug discovery informatics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
ChemAxon social profiles
Digital presenceChemAxon financial estimates
Financial estimateRevenue estimate
Valuation estimate
ChemAxon leadership team
Management profileNumber of profiles
Profiles3 records
ChemAxon funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ChemAxon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ChemAxon
What does ChemAxon do?
ChemAxon develops and licenses cheminformatics software for drug discovery. Its product suite covers property calculation, molecule design, chemical drawing, chemical search, and compound data management across the design-make-test-analyze (DMTA) cycle. Core offerings include Marvin (chemical drawing), Design Hub (collaborative molecular design), Compound Registration, Compliance Checker / cHemTS, JChem Engines (chemical search), and Discovery Toolkits (SDKs for custom cheminformatics applications).
Is ChemAxon a public or private company?
ChemAxon is a private company. It is classified as corporate owned and is currently acquired.
When was ChemAxon founded?
ChemAxon was founded in 1998. It employs 101 to 250 people.
Where is ChemAxon based?
ChemAxon is headquartered in Utica, United States, in the North America region.
How does ChemAxon make money?
One revenue line is on record: software Licensing.
Who are ChemAxon's main competitors?
Molecular Connections is listed as a regional player. Broad incumbents are BIOVIA (Dassault Systèmes), Elsevier (Reaxys) and PerkinElmer Informatics (Revvity Signals). Emerging players are Collaborative Drug Discovery (CDD) and Scilligence. Direct peers are Schrödinger, Dotmatics, ACD/Labs and OpenEye Scientific (Cadence Design Systems).
Does ChemAxon have an API?
No public API is recorded for ChemAxon.
What industry is ChemAxon in?
ChemAxon's product category is Cheminformatics Software. Its primary akta.pro industry code is HLAGAJAE, Cheminformatics & Molecular Modeling / CADD, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization.